Efficacy and Safety of Single Agent Sunitinib in Treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: A Prospective, Open-label, Phase II Study
mag（2013）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined